Design of RISC Processor Using VHDL and Cadence

S. Moslehpour,Chandrasekhar Puliroju,A. Abu-aisheh

DOI: https://doi.org/10.1007/978-90-481-3660-5_89

Abstract:

What problem does this paper attempt to address?

The antibacterial activity and mechanism of a novel peptide MR-22 against multidrug-resistant Escherichia coli

Chunren Tian,Na Zhao,Longbing Yang,Fei Lin,Ruxia Cai,Yong Zhang,Jian Peng,Guo Guo

DOI: https://doi.org/10.3389/fcimb.2024.1334378

IF: 6.073

2024-01-25

Frontiers in Cellular and Infection Microbiology

Abstract:Introduction: Bacterial infections have become serious threats to human health, and the excessive use of antibiotics has led to the emergence of multidrug-resistant (MDR) bacteria. E. coli is a human bacterial pathogen, which can cause severe infectious. Antimicrobial peptides are considered the most promising alternative to traditional antibiotics. Materials and methods: The minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC) and hemolytic activity were determined by the microdilution method. The antimicrobial kinetics of MR-22 against E. coli were studied by growth curves and time-killing curves. The cytotoxicity of MR-22 was detected by the CCK-8 assay. The antimicrobial activity of MR-22 in salt, serum, heat and trypsin was determined by the microdilution method. The antimicrobial mechanism of MR-22 against drug-resistant E. coli was studied by Scanning Electron Microscope, laser confocal microscopy, and Flow Cytometry. The in vivo antibacterial activity of MR-22 was evaluated by the mice model of peritonitis. Results and discussion: In this study, MR-22 is a new antimicrobial peptide with good activity that has demonstrated against MDR E. coli . The antimicrobial activity of MR-22 exhibited stability under conditions of high temperature, 10% FBS, and Ca 2+ . However, a decline of the activity was observed in the presence of Na + , serum, and trypsin. MR-22 had no significant cytotoxicity or hemolysis in vitro . SEM and fluorescent images revealed that MR-22 could disrupt the integrity of cell membrane. DCFH-DA indicated that MR-22 increased the content of reactive oxygen species, while it decreased the content of intracellular ATP. In mice model of peritonitis, MR-22 exhibited potent antibacterial activity in vivo . These results indicated that MR-22 is a potential drug candidate against drug-resistant E. coli .

immunology,microbiology
The antimicrobial effect of a novel peptide LL-1 on Escherichia coli by increasing membrane permeability

Lingling Zhou,Kaiqi Lian,Mengting Wang,Xueyi Jing,Yuanchen Zhang,Jinling Cao

DOI: https://doi.org/10.1186/s12866-022-02621-y

IF: 4.465

2022-09-20

BMC Microbiology

Abstract:The widespread use of antibiotics has led to the emergence of many drug-resistant strains; thus, the development of new antibacterial drugs is essential with antimicrobial peptides becoming the focus of research. This study assessed the antibacterial effect of a novel antimicrobial peptide, named LL-1 on Escherichia coli ( E.coli ) by determining the minimum inhibitory concentration (MIC) and the antibacterial curve. The interaction between LL-1 and E. coli DNA was then detected by nucleic acid gel electrophoresis. The effect of LL-1 on the E. coli cell membrane was assessed by detecting the leakage of β-galactosidase, nucleic acid and protein. The influence of LL-1 on the intracellular ATP of E. coli was analysed by determining the concentration of intracellular ATP. Finally, the bacteria and colonies of E. coli treated with LL-1 were observed using scanning and transmission electron microscopy.

microbiology
Efficacy of antimicrobial peptides (AMPs) against Escherichia coli and bacteria morphology change after AMP exposure

Yu-Tzu Huang,Selvaraj Rajesh Kumar,Hao-Chun Chan,Zih-Huei Jhan,Dave W. Chen,Shingjiang Jessie Lue

DOI: https://doi.org/10.1016/j.jtice.2021.07.003

IF: 5.477

2021-09-01

Journal of the Taiwan Institute of Chemical Engineers

Abstract:The antibacterial properties of six antimicrobial peptides (AMPs) are evaluated.Nanosized, microsized, and transmembrane pores are found in AMP-treated bacteria.Data of E. coli growth profiles show efficacy: MSI-594 >D-GL13K>L-GL13K> others.In recent years, bacterial drug resistance has become a major health concern worldwide owing to the limited efficacy of some traditional antibiotics after long-term usage. Here, to search for potent bacteriostatic agents, six cationic antimicrobial peptides (AMPs) were investigated. L-GL13K, D-GL13K, MSI-594, indolicidin, Ib-M6 and nisinA-S29A were selected to study their bactericidal efficiency and the antibacterial mechanisms against Escherichia coli (E. coli). In addition to half-maximal inhibitory concentration (IC50) and minimum inhibitory concentration (MIC) determinations using the standard method, the initial bacterial growth profiles at 4 h of AMP exposure were used to study the possible antibacterial mechanisms. The AMP-treated E. coli exhibited collapsed cell walls and various nanosized and microsized pores on the bacterial surface, which led to transmembrane channels and pore formation. Among the studied peptides, MSI-594, D-GL13K, and L-GL13K (in decreasing order) were identified as superior bactericidal agents, which may be attributed to the suitable conformational structure and surface charge during the interaction between these AMPs and bacteria.<ol class="links-for-figure"><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S1876107021004089-fx1_lrg.jpg">Download : Download high-res image (135KB)</a></li><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S1876107021004089-fx1.jpg">Download : Download full-size image</a></li></ol>

engineering, chemical
Identification, Synthesis, and In Vitro Activities of Antimicrobial Peptide from African Catfish against the Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli

Hedmon Okella,Steven Odongo,Didier Vertommen,Emmanuel Okello

DOI: https://doi.org/10.3390/pharmaceutics16070850

IF: 6.525

2024-06-23

Pharmaceutics

Abstract:The global surge in multi-drug resistant bacteria, including extended-spectrum β-lactamase (ESBL)-producing Escherichia coli has led to a growing need for new antibacterial compounds. Despite being promising, the potential of fish-derived antimicrobial peptides (AMPs) in combating ESBL-producing E. coli is largely unexplored. In this study, native African catfish antimicrobial peptides (NACAPs) were extracted from the skin mucus of farmed African catfish, Clarias gariepinus, using a combination of 10% acetic acid solvent hydrolysis, 5 kDa ultrafiltration, and C18 hydrophobic interaction chromatography. Peptides were then sequenced using Orbitrap Fusion Lumos Tribrid Mass Spectrometry. The identified peptides were screened for potential antibacterial activity using Random Forest and AdaBoost machine learning algorithms. The most promising peptide was chemically synthesized and evaluated in vitro for safety on rabbit red blood cells and activity against ESBL-producing E. coli (ATCC 35218) utilizing spot-on-lawn and broth dilution methods. Eight peptides ranging from 13 to 22 amino acids with molecular weights between 968.42 and 2434.11 Da were identified. Peptide NACAP-II was non-hemolytic to rabbit erythrocytes (p > 0.05) with a zone of inhibition (ZOI) of 22.7 ± 0.9 mm and a minimum inhibitory concentration (MIC) of 91.3 ± 1.2 μg/mL. The peptide is thus a candidate antibacterial compound with enormous potential applications in the pharmaceutical industry. However, further studies are still required to establish an upscale production strategy and optimize its activity and safety in vivo.

pharmacology & pharmacy
In vivo immunosuppression by synthetic pyrethroid (cypermethrin) pesticide in mice and goats.

R. Tamang,G. Jha,M. Gupta,H. Chauhan,B. Tiwary

DOI: https://doi.org/10.1016/0165-2427(88)90116-X

IF: 1.943

1988-10-01

Veterinary Immunology and Immunopathology

Abstract:
CxxC Zinc Finger Protein Derived Peptide, MF18 Functions Against Biofilm Formation

Prabha Nagaram,Mukesh Pasupuleti,Jesu Arockiaraj

DOI: https://doi.org/10.1007/s10930-020-09904-1

2020-07-03

The Protein Journal

Abstract:The major threat in modern medicine was biofilm forming bacterial related infections and they were highly tolerant to conventional antibiotics and a boundless demand for new drugs. In this regard, antimicrobial peptide (AMP) have been considered as potential alternative agents to conventional antibiotics. In this study, we have reported a CxxC zinc finger protein derived peptide, MF18 and its various biological role including activity against biofilm forming bacteria. Zinc finger protein are important in regulation of several cellular processes and wide range of molecular functions. The CxxC zinc finger protein identified from the cDNA library of a teleost fish; further it was characterised using various online bioinformatics programs. During the in-silico analysis, an AMP named MF18 was identified from the CxxC zinc finger protein, then it was synthesised for further biological activity studies. The antimicrobial activity of MF18 was confirmed against the biofilm clinical isolates such as Staphylococcus aureus and Escherichia coli. The MIC of the antimicrobial peptide at the concentration of 320 µM was observed against these two biofilm bacteria. The mechanism of the peptides was determined using bacteria on its membrane permeabilization ability by scanning electron microscopy. It is exhibited that the MF18 potentially influenced in damaging the morphology of the bacteria. The toxicity of MF18 against the continuous cell line (RAW 264.7) was demonstrated by MTT assay and also using peripheral red blood cells by haemolytic assay; both assays showed that the peptide have no toxicity on the cells at lower concentration. Overall, the study showed the potential therapeutic application of the peptide in pharma industry.
Design and high-level expression of a hybrid antimicrobial peptide LF15-CA8 in Escherichia coli

Xing-Jun Feng,Li-Wei Xing,Di Liu,Xue-Ying Song,Chun-Long Liu,Jing Li,Wen-Shan Xu,Zhong-Qiu Li

DOI: https://doi.org/10.1007/s10295-013-1382-3

2013-01-01

Journal of Industrial Microbiology & Biotechnology

Abstract:Antimicrobial peptides (AMPs) have been paid considerable attention owing to their broad-spectrum antimicrobial activity and have great potential as novel antimicrobials. In this study, a novel hybrid peptide LF15-CA8 was designed on the basis of bovine lactoferricin (LfcinB) and cecropin A. The gene segment encoding LF15-CA8 was synthesized and cloned into pGEX-4T-BH to form pGEX-4T-LC1 containing one copy of the LF15-CA8 coding region. A series of recombinant vectors containing up to six multiple-copy LF15-CA8 coding regions, i.e., pGEX-4T-LCn ( n = 1–6), were subsequently constructed, and used for transformation in Escherichia coli BL21(DE3). After induction with IPTG, pGEX-4T-LC1 and pGEX-4T-LC2 transformants successfully expressed fusion proteins GST-LF15-CA8 and GST-(LF15-CA8) 2 in the form of inclusion bodies, respectively. The inclusion bodies were dissolved and the peptide was successfully released in 70 % formic acid in a single step. After purification, about 10.0 mg of the recombinant peptide LF15-CA8 with purity more than 97 % was obtained from 1 l of bacteria culture of pGEX-4T-LC2 transformants. LF15-CA8 caused an increase in antibacterial activity against Gram-positive bacterium ( Staphylococcus aureus ATCC 25923) compared with the parent peptides and did not show obvious hemolytic activity against human erythrocytes in the range of effective antibacterial concentration. These results suggest that the peptide LF15-CA8 could be a promising candidate for therapeutic applications, and may lead to a cost-effective solution for the large-scale production of AMPs.
Oral Contraception and Blood Coagulability

Oral Contraception,P. Owren

DOI: https://doi.org/10.1136/bmj.1.5325.220

1963-01-26

British Medical Journal

Abstract:The fact that oral contraception mimics the hormonal effects of pregnancy which is associated with high levels of certain clotting factors prompted the authors to investigate whether changes in blood coagulability might be induced by oral contraception. 10 normal healthy women aged 22-42 with regular menstruation and no previous hormonal therapy served as volunteers in the study. 5 of the women received oral enavid (norethynodrel + ethinyloestradiol 3-methyl ether) medication in the standard contraceptive dosage of 5 mg a day from Menstrual Day 5 to be applied for 20 days. The other 5 women served as controls for analyzing possible physiological variations in blood coagulability during the menstrual cycle. Plasma samples were prepared according to a standardized technique as described for the methods used and stored at minus 20 degrees centigrade until assayed. Results of the coagulation study showed no definite changes occurring in the coagulation activities of the blood samples from nontreated women. Plasma samples from the women on "enavid" medication showed a shorting of the cephalin time and a definite increase in the activity of the antihemophilic A factor. The measured proconvertin activity increased slightly but significantly. These changes developed during the first and second weeks of therapy and the values showed a tendency to return to pretreatment levels soon after the drug was discontinued. It is noted that the number of women treated was small but the change in coagulability was marked and uniform.
Corrigendum: Intronless WNT10B-short variant underlies new recurrent allele-specific rearrangement in acute myeloid leukaemia

F. Lazzaroni,L. D. Giacco,D. Biasci,M. Turrini,L. Prosperi,R. Brusamolino,R. Cairoli,A. Beghini

DOI: https://doi.org/10.1038/srep46788

IF: 4.6

2017-04-26

Scientific Reports

Abstract:
Recombinant expression of a novel antimicrobial peptide consisting of human α-defensin 5 and Mytilus coruscus mytilin-1 in Escherichia coli

Ying Shan,Ying Dong,Dong Jiang

DOI: https://doi.org/10.1007/s13765-015-0109-8

2015-08-06

Journal of the Korean Society for Applied Biological Chemistry

Abstract:Antibiotic peptides are a battery of broad-spectrum antibacterial cationic polypeptides widely distributed in the plant and animal kingdoms. Among them, the human defensins are the first line of defense against pathogens and Mytilin, which is isolated from mussel serum, plays a key role in the mussel defense system. The antibacterial activity of these two peptides is generally ascribed to their overall positive charge, which enables them to disrupt bacterial membrane integrity and function. The aim of this study was to develop an effective method for the biosynthesis of a fusion peptide containing human α-defensin 5 (HD5) and Mytilin-1 in Escherichia coli to improve the antimicrobial activity. The individual HD5 and Mytilin-1 peptides were also synthesized for comparison with the fusion peptide. All the peptides, expressed as soluble fusions with the peptide thioredoxin, were isolated using a three-step purification strategy involving nickel-Sepharose chromatography, enterokinase cleavage, and cationic exchange chromatography. The identity of the peptides was confirmed by SDS-PAGE. Antimicrobial activity assays demonstrated that all the recombinant peptides had strong bactericidal properties and that the HD5 and Mytilin-1 fusion protein displayed higher activity against E. coli and Staphylococcus aureus. The results of this study provide a platform for the development of novel cationic peptides for biological studies.
Antibacterial and Antibiofilm Activities of Novel Antimicrobial Peptides against Multidrug-Resistant Enterotoxigenic Escherichia Coli

Kang-Chi Wu,Kuo-Feng Hua,Yu-Hsiang Yu,Yeong-Hsiang Cheng,Ting-Ting Cheng,Yao-Kuan Huang,Hui-Wen Chang,Wei-Jung Chen

DOI: https://doi.org/10.3390/ijms22083926

IF: 5.6

2021-04-10

International Journal of Molecular Sciences

Abstract:Post-weaning diarrhea due to enterotoxigenic Escherichia coli (ETEC) is a common disease of piglets and causes great economic loss for the swine industry. Over the past few decades, decreasing effectiveness of conventional antibiotics has caused serious problems because of the growing emergence of multidrug-resistant (MDR) pathogens. Various studies have indicated that antimicrobial peptides (AMPs) have potential to serve as an alternative to antibiotics owing to rapid killing action and highly selective toxicity. Our previous studies have shown that AMP GW-Q4 and its derivatives possess effective antibacterial activities against the Gram-negative bacteria. Hence, in the current study, we evaluated the antibacterial efficacy of GW-Q4 and its derivatives against MDR ETEC and their minimal inhibition concentration (MIC) values were determined to be around 2~32 μg/mL. Among them, AMP Q4-15a-1 with the second lowest MIC (4 μg/mL) and the highest minimal hemolysis concentration (MHC, 256 μg/mL), thus showing the greatest selectivity (MHC/MIC = 64) was selected for further investigations. Moreover, Q4-15a-1 showed dose-dependent bactericidal activity against MDR ETEC in time–kill curve assays. According to the cellular localization and membrane integrity analyses using confocal microscopy, Q4-15a-1 can rapidly interact with the bacterial surface, disrupt the membrane and enter cytosol in less than 30 min. Minimum biofilm eradication concentration (MBEC) of Q4-15a-1 is 4× MIC (16 μg/mL), indicating that Q4-15a-1 is effective against MDR ETEC biofilm. Besides, we established an MDR ETEC infection model with intestinal porcine epithelial cell-1 (IPEC-1). In this infection model, 32 μg/mL Q4-15a-1 can completely inhibit ETEC adhesion onto IPEC-1. Overall, these results suggested that Q4-15a-1 may be a promising antibacterial candidate for treatment of weaned piglets infected by MDR ETEC.

biochemistry & molecular biology,chemistry, multidisciplinary
Development of Antibacterial Peptides with Membrane Disruption and Folate Pathway Inhibitory Activities against Methicillin-Resistant Staphylococcus aureus

Chunlei Li,Ziyi Zhou,Weitao Wang,Yanqiu Zhao,Xin Yin,Yiwei Meng,Peipei Zhao,Mengmeng Wang,Xueting Liu,Xinye Wang,Shenlin Wang,Biao Ren,Lixin Zhang,Xuekui Xia

DOI: https://doi.org/10.1021/acs.jmedchem.3c01360

IF: 8.039

2024-01-05

Journal of Medicinal Chemistry

Abstract:Antimicrobial peptides (AMPs) offer an opportunity to overcome multidrug resistance. Here, novel peptides were designed based on AMP fragments derived from sea cucumber hemolytic lectin to enhance anti-methicillin-resistant Staphylococcus aureus (MRSA) activity with less side effects. Two designed peptides, CGS19 (LARVARRVIRFIRRAW-NH2) and CGS20 (RRRLARRLIFFIRRAW-NH2), exhibited strong antibacterial activities against clinically isolated MRSA with MICs of 3-6 μM, but no obvious cytotoxicity was...

chemistry, medicinal
Comparing bacterial membrane interactions and antimicrobial activity of porcine lactoferricin-derived peptides.

F F Han,Y H Gao,C Luan,Y G Xie,Y F Liu,Y Z Wang

DOI: https://doi.org/10.3168/jds.2012-6104

IF: 4.225

2013-01-01

Journal of Dairy Science

Abstract:Antibiotic treatment for microbial infections is under scrutiny due to increasing resistance to conventional antibiotics, warranting discovery of new classes of antibiotic agents. Antimicrobial peptides are part of the innate defense system found in nearly all organisms and possess bactericidal mechanisms that make it more difficult for bacteria to develop resistance. Porcine lactoferricin (LFP-20) is an antimicrobial peptide located in the N terminus of lactoferrin (LF). To develop novel cell-selective antimicrobial peptides with improved antimicrobial specificity compared with LFP-20, analogs LF2A LF-2, LF-4, and LF-6 were substituted with Ala, Ser, or Trp residues at different positions in the molecule. Analogs displayed a 2- to 16-fold higher antimicrobial activity than LFP-20, but were hemolytic at 64μg/mL. Additionally, LFP-20, LF2A, LF-2, and LF-4 exhibited lower cytotoxicity against human peripheral blood mononuclear cells than LF-6 at concentrations of 25 to 100μg/mL. To better understand the antibacterial mechanisms of LFP-20 and its analogs we examined their effect on the cytoplasmic membrane of Escherichia coli. The LFP-20 was not effective in depolarizing cytoplasmic membranes, whereas the other 3 analogs gradually dissipated the membrane potential of E. coli. Membrane potential increased with minimal inhibitory concentrations changes, demonstrating a correlation between bactericidal activity and membrane depolarization. Analogs were more efficient than LFP-20 in displacing lipopolysaccharide-bound dansyl-polymyxin B, which also rapidly increased 1-N-phenyl-naphthylamine uptake and release of cytoplasmic β-galactosidase by increasing the permeability of the outer and inner membranes of E. coli. The 3 analogs caused an increased potential for calcein leakage from negatively charged lipid vesicles at high concentrations. Collectively, these results suggest that the first targets of LF-2, LF-4, and LF-6 in E. coli are cytoplasmic membranes. The 3 analogs exhibited lethal effects based on their abilities to disrupt membranes and permit transit of large intracellular components, such as calcein.
Antimicrobial Activities and Membrane-Active Mechanism of CPF-C1 Against Multidrug-Resistant Bacteria, a Novel Antimicrobial Peptide Derived from Skin Secretions of the Tetraploid Frog Xenopus Clivii.

Junqiu Xie,Yuanmei Gou,Qian Zhao,Kairong Wang,Xiongli Yang,Jiexi Yan,Wei Zhang,Bangzhi Zhang,Chi Ma,Rui Wang

DOI: https://doi.org/10.1002/psc.2679

2014-01-01

Journal of Peptide Science

Abstract:Hospital‐acquired infections caused by multidrug‐resistant bacteria pose significant challenges for treatment, which necessitate the development of new antibiotics. Antimicrobial peptides are considered potential alternatives to conventional antibiotics. The skin of Anurans (frogs and toads) amphibians is an extraordinarily rich source of antimicrobial peptides. CPF‐C1 is a typical cationic antimicrobial peptide that was originally isolated from the tetraploid frog Xenopus clivii. Our results showed that CPF‐C1 has potent antimicrobial activity against both sensitive and multidrug‐resistant bacteria. It disrupted the outer and inner membranes of bacterial cells. CPF‐C1 induced both propidium iodide uptake into the bacterial cell and the leakage of calcein from large liposome vesicles, which suggests a mode of action that involves membrane disturbance. Scanning electron microscopy and transmission electron microscopy verified the morphologic changes of CPF‐C1‐treated bacterial cells and large liposome vesicles. The membrane‐dependent mode of action signifies that the CPF‐C1 peptide functions freely and without regard to conventional resistant mechanisms. Additionally, it is difficult for bacteria to develop resistance against CPF‐C1 under this action mode. Other studies indicated that CPF‐C1 had low cytotoxicity against mammalian cell. In conclusion, considering the increase in multidrug‐resistant bacterial infections, CPF‐C1 may offer a new strategy that can be considered a potential therapeutic agent for the treatment of diseases caused by multidrug‐resistant bacteria. Copyright © 2014 European Peptide Society and John Wiley & Sons, Ltd.
The Designed Pore-Forming Antimicrobial Peptide C14R Combines Excellent Activity against the Major Opportunistic Human Pathogen Pseudomonas aeruginosa with Low Cytotoxicity

Vanessa Mildenberger,Daniel Alpízar-Pedraza,Ernesto M. Martell-Huguet,Markus Krämer,Grigory Bolotnikov,Anselmo J. Otero-Gonzalez,Tanja Weil,Armando Rodriguez-Alfonso,Nico Preising,Ludger Ständker,Verena Vogel,Barbara Spellerberg,Ann-Kathrin Kissmann,Frank Rosenau

DOI: https://doi.org/10.3390/ph17010083

IF: 4.6

2024-01-10

Pharmaceuticals

Abstract:The diminishing portfolio of mankind's available antibiotics urges science to develop novel potent drugs. Here, we present a peptide fitting the typical blueprint of amphipathic and membrane-active antimicrobial peptides, denominated C14R. This 2 kDa peptide consists of 16 amino acid residues, with seven being either hydrophobic, aromatic, or non-polar, and nine being polar or positively charged, strictly separated on opposite sides of the predicted α-helix. The affinity of the peptide C14R to P. aeruginosa membranes and its intrinsic tendency to productively insert into membranes of such composition were analyzed by dynamic simulations. Its biological impact on the viability of two different P. aeruginosa reference strains was demonstrated by determining the minimal inhibitory concentrations (MICs), which were found to be in the range of 10–15 μg/mL. C14R's pore-forming capability was verified in a permeabilization assay based on the peptide-triggered uptake of fluorescent dyes into the bacterial cells. Finally, the peptide was used in radial diffusion assays, which are commonly used for susceptibility testing of antimicrobial peptides in clinical microbiology. In comparison to reference strains, six clinical P. aeruginosa isolates were clearly affected, thereby paving the way for further in-depth analyses of C14R as a promising new AMP drug in the future.

pharmacology & pharmacy,chemistry, medicinal
Design, expression, and characterization of a novel cecropin A-derived peptide with high antibacterial activity

Meng Wang,Jinglian Lin,Qiuli Sun,Kaiwen Zheng,Yi Ma,Jufang Wang

DOI: https://doi.org/10.1007/s00253-018-09592-z

IF: 5

2019-01-04

Applied Microbiology and Biotechnology

Abstract:In recent years, antimicrobial peptides have received increased interest and are potential substitutes for antibiotics. However, natural antimicrobial peptides are always toxic to mammalian cells and usually exhibit weak antibacterial activity, which restrict their wide application. In this study, a novel antibacterial peptide named PEW300 was designed with three mutations to the parental peptide cecropin A. As predicted by bioinformatic programs, the positive charge of PEW300 increased from + 6 to + 9 compared with cecropin A, and the grand average of hydropathicity increased from − 0.084 to − 0.008. Expression of PEW300 resulted in serious inhibition of Escherichia coli BL21(DE3) cells, indicating designed PEW300 may have stronger antibacterial activity. A simple, fast, and low-cost approach without tedious protein purification steps was selected for the efficient production of PEW300 by fusion with ELK16 and about 7.38 μg/mg wet cell weight PEW300 was eventually obtained. Purified PEW300 exhibited strong antibacterial activity against various Gram-positive and Gram-negative bacteria which was enhanced four- to sevenfold compared with the parental peptide cecropin A. Besides, PEW300 had no hemolytic activity toward mammalian cells even at high concentration (224 ng/μl). PEW300 showed good stability in neutral and alkaline solutions. Moreover, PEW300 was thermally stable even at up to 100 °C and resistant to proteinase K, pepsin, snailase, and trypsin. The incubation with human serum had no effect on the antibacterial activity of PEW300. All these results demonstrated that PEW300 designed in this work may have good potential as a candidate pharmaceutical agent.

biotechnology & applied microbiology
Bactericidal Efficiency and Mechanism of Specifically Targeted Antimicrobial Peptides Optimized Based on Structural and Functional Relationships

Peng Tan,Zhenheng Lai,Yongjie Zhu,Changxuan Shao,Muhammad Usman Akhtar,Weifen Li,Xin Zheng,Anshan Shan

DOI: https://doi.org/10.1101/679977

2019-01-01

ACS Biomaterials Science & Engineering

Abstract:In contrast to traditional broad-spectrum antibiotics, it is difficult for bacteria to develop resistance to most specifically targeted antimicrobial peptides (STAMPs), moreover, they can maintain a normal ecological balance and provide long-term protection for the body. However, therapeutic applications of STAMPS are hindered by their weak activity, and imperfect specificity as well as lack of knowledge to understand their structure-activity relationships. To further investigate the effects of different parameters on the biological activities of STAMPs, a peptide sequence, WKKIWKDPGIKKWIK, was truncated, extended, and provided with an increased charge and altered amphipathicity. In addition, a novel template modification method was introduced, in which a phage-displayed peptide that recognized and bound to E. coli cells was attached at the end of the sequence. Compared with the traditional template modification method, peptide 11, which contained a phage-displayed peptide at the C-terminus, exhibited superior narrow-spectrum antibacterial activity against E. coli compared to that of parental peptide 2, and the activity and specificity of 11 were increased by 5.0 and 2.4 times, respectively. Additionally, 11 showed low cell toxicity and relatively desirable salt, serum, acid and alkaline stability. In this study, 11 specifically killed E. coli by causing cytoplasmic membrane rupture and cytosol leakage. In summary, these findings are useful for improving the activity and specificity of STAMPs and show that peptide 11 is better able to combat the growing threat of E. coli infections.
Identification and Rational Design of a Novel Antibacterial Peptide Dermaseptin-AC from the Skin Secretion of the Red-Eyed Tree Frog Agalychnis callidryas

Zijian Gong,Xinjie Pei,Shen Ren,Xiaoling Chen,Lei Wang,Chengbang Ma,Xinping Xi,Tianbao Chen,Chris Shaw,Mei Zhou

DOI: https://doi.org/10.3390/antibiotics9050243

2020-05-10

Abstract:Antibiotic resistance represents a tremendous contemporary clinical challenge. Given this challenge, antimicrobial peptides (AMPs) are regarded as one of the most promising new options for next-generation lead antibiotics. Here, we describe the antibacterial activities of a cationic peptide named DRP-AC4, obtained from frog skin secretion using shotgun cloning. Two modified peptides were derived by substituting the sequence of amino acids to complete the hydrophobic face (DRP-AC4b) and increase net charge (DRP-AC4a), respectively. The activity and cytotoxicity of these two peptides were compared. DRP-AC4a displayed significantly increased potency against bacteria compared to the natural peptide. It should be noted, however, that both analogue peptides demonstrated higher lytic ability than the natural peptide against the membranes of mammalian erythrocytes. At the same time, all three peptides displayed lower hemolytic activity compared to their antibacterial activity. Here, we demonstrate that AMPs have more complex activity mechanisms and faster bactericidal rates than traditional antibiotics, which may be one of the reasons why bacteria do not develop resistance to them. These discoveries provide interesting insights into the discovery and development of novel drugs from natural sources.
Antibacterial efficacy and mechanism of Cyprinus carpio chemokine-derived L-10 against multidrug-resistant Escherichia coli infections

Hao Lu,Chenchen Wang,Wenjia Lu,Xiaodan Li,Gaoyan Wang,Wenqi Dong,Xiangru Wang,Huanchun Chen,Chen Tan

DOI: https://doi.org/10.1016/j.ijantimicag.2024.107104

IF: 15.441

2024-03-09

International Journal of Antimicrobial Agents

Abstract:Objectives Antimicrobial resistance has raised concerns regarding untreatable infections and poses a growing threat to public health. Rational design of new AMPs is an ideal solution to this threat. Methods In this study, we designed, modified, and synthesised an excellent AMP, L -10, based on the original sequence of the Cyprinus carpio chemokine. All experimental data were presented as the mean ± standard deviation (SD), and the two-tailed unpaired T-test method was used to analyze all data. Results L-10 exhibited excellent antibacterial activity with negligible toxicity and improved the efficacy of a broad class of antibiotics against MDR Gram-negative pathogens, including tetracycline, meropenem, levofloxacin, and rifampin. Mechanistic studies have suggested that L -10 targets the bacterial membrane components, LPS and PG, to disrupt bacterial membrane integrity, thereby exerting antibacterial effects and enhancing the efficacy of antibiotics. Moreover, in animal infection models, L -10 significantly increased the survival rate of infected animals and effectively reduced the tissue bacterial load and inflammatory factor levels. In addition to its direct antibacterial activity, L -10 dramatically reduced pulmonary pathological alterations in a mouse model of endotoxemia and suppressed LPS-induced proinflammatory cytokines in vitro and in vivo . Lastly, L -10 was successfully expressed in Pichia pastoris and maintained antimicrobial activity against MDR Gram-negative pathogens in vivo and in vitro . Conclusion Collectively, these results reveal the potential of L -10 as an ideal candidate against MDR bacterial infections and provide new insights into the design, development, and clinical application of AMPs.

pharmacology & pharmacy,infectious diseases,microbiology
Novel antimicrobial peptide CPF-C1 analogs with superior stabilities and activities against multidrug-resistant bacteria

Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,Rui Wang

DOI: https://doi.org/10.1111/cbdd.12988

Abstract:As numerous clinical isolates are resistant to most conventional antibiotics, infections caused by multidrug-resistant bacteria are associated with a higher death rate. Antimicrobial peptides show great potential as new antibiotics. However, a major obstacle to the development of these peptides as useful drugs is their low stability. To overcome the problem of the natural antimicrobial peptide CPF-C1, we designed and synthesized a series of analogs. Our results indicated that by introducing lysine, which could increase the number of positive charges, and by introducing tryptophan, which could increase the hydrophobicity, we could improve the antimicrobial activity of the peptides against multidrug-resistant strains. The introduction of d-amino acids significantly improved stability. Certain analogs demonstrated antibiofilm activities. In mechanistic studies, the analogs eradicated bacteria not just by interrupting the bacterial membranes, but also by linking to DNA, which was not impacted by known mechanisms of resistance. In a mouse model, certain analogs were able to significantly reduce the bacterial load. Among the analogs, CPF-9 was notable due to its greater antimicrobial potency in vitro and in vivo and its superior stability, lower hemolytic activity, and higher antibiofilm activity. This analog is a potential antibiotic candidate for treating infections induced by multidrug-resistant bacteria.

Design of RISC Processor Using VHDL and Cadence

The antibacterial activity and mechanism of a novel peptide MR-22 against multidrug-resistant Escherichia coli

The antimicrobial effect of a novel peptide LL-1 on Escherichia coli by increasing membrane permeability

Efficacy of antimicrobial peptides (AMPs) against Escherichia coli and bacteria morphology change after AMP exposure

Identification, Synthesis, and In Vitro Activities of Antimicrobial Peptide from African Catfish against the Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli

In vivo immunosuppression by synthetic pyrethroid (cypermethrin) pesticide in mice and goats.

CxxC Zinc Finger Protein Derived Peptide, MF18 Functions Against Biofilm Formation

Design and high-level expression of a hybrid antimicrobial peptide LF15-CA8 in Escherichia coli

Oral Contraception and Blood Coagulability

Corrigendum: Intronless WNT10B-short variant underlies new recurrent allele-specific rearrangement in acute myeloid leukaemia

Recombinant expression of a novel antimicrobial peptide consisting of human α-defensin 5 and Mytilus coruscus mytilin-1 in Escherichia coli

Antibacterial and Antibiofilm Activities of Novel Antimicrobial Peptides against Multidrug-Resistant Enterotoxigenic Escherichia Coli

Development of Antibacterial Peptides with Membrane Disruption and Folate Pathway Inhibitory Activities against Methicillin-Resistant Staphylococcus aureus

Comparing bacterial membrane interactions and antimicrobial activity of porcine lactoferricin-derived peptides.

Antimicrobial Activities and Membrane-Active Mechanism of CPF-C1 Against Multidrug-Resistant Bacteria, a Novel Antimicrobial Peptide Derived from Skin Secretions of the Tetraploid Frog Xenopus Clivii.

The Designed Pore-Forming Antimicrobial Peptide C14R Combines Excellent Activity against the Major Opportunistic Human Pathogen Pseudomonas aeruginosa with Low Cytotoxicity

Design, expression, and characterization of a novel cecropin A-derived peptide with high antibacterial activity

Bactericidal Efficiency and Mechanism of Specifically Targeted Antimicrobial Peptides Optimized Based on Structural and Functional Relationships

Identification and Rational Design of a Novel Antibacterial Peptide Dermaseptin-AC from the Skin Secretion of the Red-Eyed Tree Frog Agalychnis callidryas

Antibacterial efficacy and mechanism of Cyprinus carpio chemokine-derived L-10 against multidrug-resistant Escherichia coli infections

Novel antimicrobial peptide CPF-C1 analogs with superior stabilities and activities against multidrug-resistant bacteria